Objective evaluation of clinical outcomes of laparoscopy-assisted pylorus-preserving gastrectomy for middle-third early gastric cancer

BMC Cancer. 2019 May 22;19(1):481. doi: 10.1186/s12885-019-5695-0.

Abstract

Background: Laparoscopic-assisted pylorus-preserving gastrectomy (LAPPG) is a minimally invasive function-preserving surgery for early gastric cancer. This study was designed to investigate the clinical outcomes between LAPPG and laparoscopy-assisted distal gastrectomy (LADG) by objective evaluation.

Methods: A total 167 pT1N0M0 gastric cancer patients underwent LAPPG(n = 70) and LADG(n = 97) were retrospectively analyzed. By evaluating the functional advantages, objective short-term and one year follow-up outcomes were compared.

Results: There is no significant difference in perioperative clinical characteristics as well as pathologic results between LAPPG and LADG group while the cost is higher in latter(p = 0.004). The Clavien-Dindo grade II or higher complications were 15.7 and 13.4% in LAPPG and LADG group respectively(p = 0.824). In one year follow-up, nutritional status was significantly better in LAPPG group accompanied by better pylorus function preserving.

Conclusion: LAPPG is an acceptable surgical procedure for pT1N0M0 middle portion gastric cancer patients in terms of nutritional and economic advantage.

Trial registration: Chinese Clinical Trial Registry ( ChiCTR-PIC-17012358 , Date of Registration:2017-08-14).

Keywords: Gallstone; Gastric emptying; Laparoscopic-assisted pylorus-preserving gastrectomy; Nutritional status; pT1N0M0 gastric cancer.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Aged
  • Female
  • Gastrectomy / methods*
  • Humans
  • Laparoscopy
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Nutritional Status
  • Organ Sparing Treatments / methods*
  • Pylorus
  • Retrospective Studies
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Treatment Outcome